In fact, basic scientists were pessimistic about the feasibility of human transplantation. For example, in his book The Biological Basis of Individuality, Dr Leo Loeb categorically stated that transplantation between individual humans would never be possible. Although his thesis was accepted as dogma by some, it did not seem irrefutable to me. Surgeons, by nature, tend to be optimists.
-Joseph Murray P rior to the 1900s, it seemed that human organ transplantation would be an impossible feat. Several attempts had been made but all had ended in rejection of the donor kidney. Thanks to the groundbreaking work of Dr Joseph Murray in the 1950s and 1960s, renal transplants now take place throughout the world on a daily basis. Murray was the first surgeon to successfully perform renal transplantation, first in identical twins, then in non-identical twins and, finally, using a cadaveric donor. For his pioneering work concerning organ transplantation in the treatment of human diseases, Murray was awarded the Nobel Prize in Physiology or Medicine in 1990. To further Murray's interest in transplantation, Dr James Barrett Brown, chief of surgery at Valley Forge General Hospital at the time, shared his own experiences in treating burn patients. He observed that the closer the donor's genetic relationship to the patient was, the more resistant the graft was to rejection. Dr Brown had previously grafted skin between identical twins and documented the first case of permanent survival of the donor tissue. Murray himself also noted experiments by Prof Thomas Gibson and Sir Peter Medawar that reported how the transplantation of a second skin allograft from the same donor was rejected more rapidly than the first, implying that an immunologic process was the cause of transplant rejection.
L I B E R A L B E G I N N I N G S

A C H A N C E E N CO U N T E R
After the war was over, Murray returned to Boston to continue training in plastic reconstructive surgery, but increasingly began pursuing his transplant interests. He realised that overcoming the immunologic barrier in organ transplantation would be a monumental challenge. Many of his peers discounted his pursuit, believing that the problem of immune rejection was insurmountable. At the same time, as Murray was aware that no cure for patients with end-stage renal disease then existed, he proceeded with experiments to determine whether a transplanted kidney would function properly if immune rejection could be avoided. He performed renal transplants on dogs, which did not develop severe transplant rejections, unlike humans. Murray not only perfected vascular and ureteral anastomoses Joseph Murray (1919 -2012 
B R E A K T H R O U G H Murray used several techniques
to prevent graft rejections in genetically non-identical hosts. He first used total body irradiation, followed by bone marrow replacement, which was initially successful in an operation between two non-genetically identical twins. The 24-year-old recipient, John Riteris, lived 29 years after the transplant. However, the approach proved unreliable in suppressing the recipient's immune system, and the results could not be consistently reproduced. In 1959, a major breakthrough occurred when 6-mercaptopurine was used by Dr Robert S Schwartz and Dr William Dameshek to prevent antibody production in rabbits against human serum albumin. Murray initially used 6-mercaptopurine in dogs and later azathioprine, a less toxic immunosuppressant developed by British researcher Roy Calne, which resulted in a marked increase in allograft survival. In 1961, Murray performed the first unrelated kidney transplant in humans using immunosuppressive therapy. The transplant functioned well, but the patient died from drug toxicity. In his second attempt, Murray was initially able to control and reverse the rejection phenomenon by starting azathioprine, which was later discontinued when leucopenia developed. Rejection of the kidney occurred soon after and azathioprine was readministered, with subsequent improvement in renal function. However, the patient died of a severe infection thereafter. The third patient, 23-year-old Mel Doucette, survived for over a year following what is considered the first successful renal allograft. As protocols for renal transplantation were refined and new immunosuppressant agents became available, survival rates increased dramatically, leading to the establishment of national donor programmes and the International Renal Transplant Registry. After the success of renal transplants, other organ transplants soon followed, including those of the liver and heart.
F O L L O W I N G H I S H E A R T Notwithstanding his
pioneering work in human transplantation, Murray's true passion was still reconstructive surgery. In choosing between the two, he decided to step down as chief of transplant surgery at Peter Bent Brigham Hospital in 1971 to focus on paediatric reconstructive surgery, becoming the chief of plastic surgery at the Boston Children's Hospital Medical Center in Boston. He developed procedures for repairing birth defects and treating paediatric burn victims. In 1986, Murray suffered a stroke and, following a quick recovery, retired to spend time with his wife, six children and many grandchildren. To cap off his illustrious career, Murray received the Nobel prize in Physiology or Medicine in 1990, together with Dr Edward Donnall Thomas, for his contributions to the advancement of transplantation medicine. A friend and colleague of Murray, Dr Francis Moore, joked, "Joe's the only guy who ever won a Nobel Prize for pursuing a hobby." In 2001, Murray wrote his autobiography, Surgery of the Soul: Reflections on a Curious Career, which recounts his encounter with Charles Woods as well as other patients who had guided his career.
